Using regadenoson for stress first-pass perfusion cardiac MR imaging: How, when, and why?
Diagnostic and Interventional Imaging · 2026
DOI: 10.1016/j.diii.2026.01.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostic and Interventional Imaging, 2026. Verfasst von Bon-Marin Mulot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University Hospital of Rouen 76000 Rouen, France. Hauptthemen laut MEDLINE: Purines, Pyrazoles, Myocardial Perfusion Imaging, Adenosine A2 Receptor Agonists. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Cardiac magnetic resonance imaging (MRI) is a valuable tool for ruling out coronary artery disease, assessing cardiac viability, diagnosing myocardial ischemia, and providing prognostic information. Cardiac MRI, including vasodilator-induced first-pass perfusion imaging, is recommended for patients with a high probability of coronary disease, prior to revascularization, and when a viability assessment is necessary. Adenosine is the most commonly used vasodilating agent for stress cardiac MRI worldwide. However, regadenoson, which is an adenosine A2A receptor agonist, is a highly suitable alternative for stress cardiac MRI due to its kinetic properties, ease of use, single-dose administration, limited contraindications, and prognostic value. This technical note describes the characteristics and safety profile of regadenoson and discusses its application to cardiac MRI and reimbursement issues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University Hospital of Rouen 76000 Rouen, France.
- Department of Radiology, University Hospital of Rouen 76000 Rouen, France; UNIROUEN, INSERM U1096, UFR Santé, 76183, Rouen, France.
- Department of Radiology, University Hospital of Rouen 76000 Rouen, France; UNIROUEN, INSERM U1096, UFR Santé, 76183, Rouen, France. Electronic address: jean-nicolas.dacher@chu-rouen.fr.
Zitieren
APA
Mulot, B. M., Chennoufi, H., Demeyere, M., Boccalini, S., & Dacher, J. N. (2026). Using regadenoson for stress first-pass perfusion cardiac MR imaging: How, when, and why?. Diagnostic and Interventional Imaging. https://doi.org/10.1016/j.diii.2026.01.001
Vancouver
Mulot BM, Chennoufi H, Demeyere M, Boccalini S, Dacher JN. Using regadenoson for stress first-pass perfusion cardiac MR imaging: How, when, and why?. Diagnostic and Interventional Imaging. 2026. doi:10.1016/j.diii.2026.01.001
BibTeX
@article{Mulot2026,
author = {Mulot, Bon-Marin and Chennoufi, Hajer and Demeyere, Matthieu and Boccalini, Sara and Dacher, Jean-Nicolas},
title = {Using regadenoson for stress first-pass perfusion cardiac MR imaging: How, when, and why?},
journal = {Diagnostic and Interventional Imaging},
year = {2026},
doi = {10.1016/j.diii.2026.01.001}
}
EUVIMED